Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Genetic screening on health council agenda:

This article was originally published in Clinica

Executive Summary

The implications of genetic screening is one of the key issues on the agenda at the seventh conference of European Health Ministers on June 12 and 13. The meeting, entitled Health, Dignity and Human Rights will also discuss the organisation and financing of healthcare services, as well as how to forge alliances between countries to respond effectively on a pan-European level to global health threats, such as the SARS virus. The conference is expected to call on the Council of Europe to pursue and intensify its work on the social, ethical and human rights dimension in the planning, delivery and availability of healthcare.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT062491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel